GT Biopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 02/17/2026 | 80.76 K | $63.41 K | 103.77% | 2.05% |
| SCIENTECH RESEARCH LLC | 02/17/2026 | 54.75 K | $42.99 K | 100.00% | 1.39% |
| SEACREST WEALTH MANAGEMENT, LLC | 01/12/2026 | 50.00 K | $36.62 K | 100.00% | 1.27% |
| JANE STREET GROUP, LLC | 02/12/2026 | 26.02 K | $20.43 K | 100.00% | 0.66% |
| INTEGRATED WEALTH CONCEPTS LLC | 02/13/2026 | 20.01 K | $15.71 K | 100.00% | 0.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 19.26 K | $15.12 K | -19.64% | 0.49% |
| MORGAN STANLEY | 02/13/2026 | 18.60 K | $14.60 K | 32.71% | 0.47% |
| COSTON, MCISAAC & PARTNERS | 02/03/2026 | 17.09 K | $13.00 K | 100.00% | 0.43% |
| CAITLIN JOHN, LLC | 02/18/2026 | 16.50 K | $12.96 K | 100.00% | 0.42% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 16.04 K | $12.59 K | 60.18% | 0.41% |
| AM INVESTMENT STRATEGIES LLC | 02/05/2026 | 15.00 K | $12.00 K | 100.00% | 0.38% |
| CERITY PARTNERS LLC | 02/11/2026 | 15.00 K | $11.78 K | 100.00% | 0.38% |
| VERDENCE CAPITAL ADVISORS LLC | 01/29/2026 | 13.00 K | $10.21 K | 100.00% | 0.33% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 12.53 K | $9.84 K | -26.55% | 0.32% |
| PROSPERA FINANCIAL SERVICES INC | 02/09/2026 | 12.00 K | $9.42 K | 100.00% | 0.30% |
| HRT FINANCIAL LP | 02/12/2026 | 11.77 K | $9.00 K | 100.00% | 0.30% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 01/13/2026 | 10.90 K | $8.56 K | 100.00% | 0.28% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 10.83 K | $8.51 K | -88.29% | 0.27% |
| LPL FINANCIAL LLC | 02/11/2026 | 10.63 K | $8.35 K | 100.00% | 0.27% |
| ADVISORY SERVICES NETWORK, LLC | 02/17/2026 | 10.00 K | $7.85 K | 100.00% | 0.25% |
| HBK SORCE ADVISORY LLC | 02/09/2026 | 10.00 K | $5.39 K | 100.00% | 0.25% |
| BLACKROCK, INC. | 02/12/2026 | 8.41 K | $6.60 K | -13.64% | 0.21% |
| WOLFF WIESE MAGANA LLC | 01/14/2026 | 5.00 K | $3.93 K | 100.00% | 0.13% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 01/21/2026 | 3.75 K | $2.95 K | 0.00% | 0.10% |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 3.00 K | $2.36 K | 100.00% | 0.08% |
| CITIGROUP INC | 02/13/2026 | 2.78 K | $2.18 K | 100.00% | 0.07% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 2.00 K | $1.58 K | -60.58% | 0.05% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 2.00 K | $1.57 K | 100.00% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.70 K | $1.34 K | -0.18% | 0.04% |
| TRIUMPH CAPITAL MANAGEMENT | 02/12/2026 | 1.66 K | $1.30 K | 100.00% | 0.04% |
| SWAN CAPITAL LLC | 02/12/2026 | 1.00 K | $785 | 100.00% | 0.03% |
| SPIRE WEALTH MANAGEMENT | 01/14/2026 | 994 | $785 | 100.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 24 | $19 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 16 | $13 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1 | $1 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 02/05/2026 | 1 | $1 | 0.00% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 1 | $1 | -99.96% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 1 | $1 | -80.00% | 0.00% |
| VANGUARD GROUP INC | 01/29/2026 | 0 | $0 | -100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 02/09/2026 | 0 | $0 | -100.00% | 0.00% |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 02/09/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
GT Biopharma Inc institutional Ownership - FAQ's
During the previous two years, 55 institutional investors and hedge funds held shares of GT Biopharma Inc. The most heavily invested institutionals were:
VANGUARD FIDUCIARY TRUST CO: 225,938
SeaCrest Wealth Management, LLC: 50,000
UBS Group AG: 45,970
LPL Financial LLC: 30,382
Private Wealth Management Group, LLC: 20,000
Coston, McIsaac & Partners: 17,092
12.26% of GT Biopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 806.06 K shares in the last 24 months. This purchase volume represents approximately $338.54 K in transactions.